Material Information of Glaxo Smith Kline Pakistan Limited.

Karachi -- Glaxo Smith Kline Pakistan Limited informed Pakistan Stock Exchange that the Company, member of the Haleon Group ("Company") has lifted the event of force majeure declared on October 21, 2022 for the captioned range of products.

The Company resumed the full capacity manufacturing of Panadol Tablets, Panadol Extra Tablets andChildren's Panadol Liquid Range once an agreement was reached with the key Federal Government'sRepresentatives.

The announcement is available at:

https://dps.psx.com.pk/download/document/197309.pdf

GlaxoSmithKline Pakistan Limited was created January 1st, 2001 through the merger of SmithKline and French of Pakistan Limited, Beecham Pakistan (Private) Limited and Glaxo Welcome (Pakistan) Limited and stands today as a pharmaceutical company in Pakistan.

GlaxoSmithKline Pakistan Limited is incorporated in Pakistan as a limited liability...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT